← All diseases Cancer

Acute myeloid leukemia

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (55)Meta-analysis (19)Randomized trial (15)Systematic review (11)Phase 3 study (10)Clinical trial (614)Review article (220)Early study (phase 1 or 2) (42)Case report (168)Laboratory or animal study (50)Commentary or editorial (47)Retracted Publication (4) Only studies currently seeking participants (44)

Filter

Publications (1514)

• The LMO2-LDB1-TAL1 complex regulates transcription networks in acute myeloid leukemia. (2025/11/25) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Breast Myeloid Sarcoma Mimicking Breast Carcinoma: A Case Report. (2025/11/21) ♡
• Network pharmacology, molecular docking, and experimental validation-based approach to explore the mechanism of action of ginsenoside Rh4 on acute myeloid leukemia cells. (2025/11/20) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Combined Inhibition of telomerase and mitochondria synergistically promote apoptosis in AML cell lines. (2025/11/18) ♡
• SKIDA1 sustains MLL::ENL-expressing hematopoietic progenitors during neonatal stages and promotes B-lineage priming. (2025/11/17) ♡
• Bone marrow accumulation of perfluoroalkyl substances (PFASs) predicts post-transplant relapse in acute myeloid leukemia patients and associated with T-cell dysregulation. (2025/11/15) ♡
• Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia. (2025/11/13) ♡
• Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors. (2025/11/06) ♡
• The clinical value of inflammatory factors in evaluating the prognosis of patients with acute myeloid leukemia. (2025/11/05) ♡
• Causal Effects of Plasma Metabolites on Leukemia: A Mendelian Randomization Study. (2025/11/03) ♡
• Nutrition and Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults (Aged ≥60): A Scoping Review. (2025/11/01) ♡
• A specific bone marrow cytokine pattern in de novo acute myeloid leukemia. (2025/11/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Targeting Metabolic Pathways in AML Cell Lines: Impact of Hypoxia-Inducible Factor-1α (HIF-1α) and Lactate Dehydrogenase-A (LDH-A) Inhibition. (2025/11/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Differentiation-Inducing Effects of Triciribine and All-Trans Retinoic Acid in Acute Myeloid Leukemia Cell lines. (2025/11/01) ♡
• Deciphering hierarchical regulatory network of cell fate via an epigenetics-informed heterogeneous graph transformer on single-cell multi-omics data. (2025/11/01) ♡
• [Allogeneic hematopoietic stem cell transplantation in children's acute myeloblastic leukemia: Survival and relapse]. (2025/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of neutropenic diet with or without magnesium supplementation on inflammatory factors and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia: study protocol for a randomized clinical trial. (2025/10/31) ♡
• Disease-specific epigenetic deregulation of enhancers, transposons, and polycomb targets in acute promyelocytic leukemia. (2025/10/30) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Pilot study of an inpatient physical activity intervention for older adults treated intensively for acute myeloid leukemia. (2025/10/28) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia. (2025/10/26) ♡
• Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance threats. (2025/10/26) ♡
• Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial. (2025/10/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of jejunal myeloid sarcoma presented with intestinal intussusception in a 19-year-old man: An uncommon presentation of a rare disease. (2025/10/16) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Pathergy beyond neutrophilic dermatoses: A case of localized leukemia cutis at the site of intravenous infiltration. (2025/10/08) ♡
• The PERK signaling pathway as a marker of the unfolded protein response in patients with acute myeloid leukemia. (2025/10/08) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Advances in Leukemia detection and classification: A Systematic review of AI and image processing techniques. (2025/10/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rehabilitation of a quadruple amputee with leukemia: A challenging endeavor. (2025/10/01) ♡
• Comparable Short Term Outcomes Among Patients with Newly Diagnosed Acute Myeloid Leukemia with or without Myelodysplasia Related Gene Mutations Treated with Azacytidine-Venetoclax: Observations from a Single Center Retrospective Cohort. (2025/10/01) ♡
• Comparative Analysis of the Therapeutic Efficacy of Decitabine Combined with Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor (D-CAG) Versus CAG Regimen in the Treatment of Acute Myeloid Leukemia. (2025/10/01) ♡
• Impact of Dasatinib on Female Reproductive Health in Philadelphia-Positive Leukemia Patients. (2025/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Co-occurrence of RUNX1::RUNX1T1 Translocation-Positive Acute Myeloid Leukemia and Smouldering Multiple Myeloma: An Uncommon Case. (2025/10/01) ♡
• Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MRD as an early endpoint in myeloma and other hematologic malignancies: Implication for ongoing and future study designs. (2025/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bilateral neurotrophic keratitis associated with Gilteritinib therapy in a patient with acute myeloid leukemia: a case report. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of MRD testing in acute myeloid leukemias. What is the status and how to get there? (2025/10/01) ♡
• Daunomycin Nanocarriers with High Therapeutic Payload for the Treatment of Childhood Leukemia. (2025/09/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Revealing a Heterozygous FCGR1A Variant in a Patient with Uveal Melanoma and Von Hippel-Lindau Syndrome: A Rare Case Report. (2025/09/18) ♡
• Research priorities to address supportive care needs in acute myeloid leukaemia (AML)-results from a Delphi survey. (2025/09/11) ♡
• TRIB1 facilitates the proliferation and migration of ovarian cancer cells by inducing EMT progression. (2025/09/01) ♡
• ZIP10 as a potential therapeutic target in acute myeloid leukaemia. (2025/09/01) ♡
• Wernicke Encephalopathy Induced by Prolonged Total Parenteral Nutrition in a 16-Year-Old Girl with Acute Myeloid Leukemia. (2025/09/01) ♡
• Single Centre Experience of Treating Children with Cancer in the United Arab Emirates. (2025/09/01) ♡
• Shifting Paradigms in Antifungal Prophylaxis and Their Effects on Candidemia Outcomes in Hematological Malignancies: A 14-Year Experience from a Single Tertiary Center. (2025/08/28) ♡
• Metabolic pathways and chemotherapy resistance in acute myeloid leukemia (AML): Insights into Enoyl-CoA hydratase domain-containing protein 3 (ECHDC3) as a potential therapeutic target. (2025/08/22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A multicenter single-arm clinical study of Chinese children's cancer group-acute promyelocytic leukemia-2017 (CCCG-APL-2017) protocol. (2025/08/22) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Maternal prenatal infection and childhood leukaemia: a Childhood Cancer and Leukemia International Consortium (CLIC) meta-analysis. (2025/08/18) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. RETRACTED: El-Garawani et al. In Vitro Induction of Apoptosis in Isolated Acute Myeloid Leukemia Cells: The Role of Anastatica hierochuntica Methanolic Extract. Metabolites 2022, 12, 878. (2025/08/12) ♡
• Suppression of UCP2 alleviates leukemogenesis by enhancing branched-chain amino acids-induced oxidative stress via activating the PI3K/AKT/mTOR signaling pathway. (2025/08/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful treatment with mesenchymal stromal cells-Frankfurt am Main in a pediatric patient with steroid-refractory and ruxolitinib-refractory acute gastrointestinal graft-versus-host disease. (2025/08/01) ♡
• SLC39A14 Is a Potential Therapy Target and Prognostic Biomarker for Acute Myeloid Leukemia. (2025/07/27) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.